Actualités
NCDconnect & ACT for Children: Closing the Paediatric Cancer Gap
In many low- and middle-income countries (LMICs), a childhood cancer diagnosis often comes with limited access to timely treatment, essential medicines, and consistent care. That’s why earlier this year, NCDconnect—through IDA Foundation—joined the Access Cancer...
Closing the Hypertension Gap in LMICs: Why BP Monitoring Is Essential
World Hypertension Day 2025 | Theme: "Measure Your Blood Pressure Accurately, Control It, Live Longer" High blood pressure (hypertension) remains one of the leading risk factors for cardiovascular disease and premature death worldwide. Yet in many low- and...
How WHO Recommendations for NCDs Impact Global Health
Noncommunicable diseases (NCDs) are among the leading causes of death and disability worldwide, posing an immense burden on healthcare systems, economies, and individuals—especially in countries with a low Human Development Index (HDI). Recognising the urgency of...
NCDconnect in The Lancet Oncology: Enhancing Cancer Care
A new article in The Lancet Oncology1 highlights the urgent need for sustainable solutions to improve cancer treatment access in low- and middle-income countries (LMICs). Authored by ATOM Coalition experts, the article outlines key barriers to medicine availability...
Best Practices for HPV DNA Tests in Cervical Screening
Cervical cancer remains one of the most preventable and treatable cancers. Yet it disproportionately affects women in countries with low Human Development Index (HDI), where screening and treatment services often face systemic challenges. Recognising this, the World...
Expanding Access to Nilotinib in Low-Income Countries
Following the agreement on a new licensing model between the Medicines Patent Pool (MPP) & Novartis in collaboration with the ATOM Coalition, generic, quality-assured nilotinib is now available on NCDconnect! This initiative is crucial in making lifesaving...
Comment s'inscrire sur NCDconnect : un Processus Simple et Rapide
Welcome to NCDconnect, your Digital Procurement Platform for essential medicines and medical devices against noncommunicable diseases (NCD). Signing up is straightforward, and this guide will help you complete the process with ease. Who can Use NCDconnect's Digital...
Childhood Cancer Medicines: Improving Access in LMICs
Every child deserves a fighting chance against cancer, regardless of where they are born. Yet, stark inequalities persist in access to pediatric oncology treatment, especially in low- and middle-income countries (LMICs). As purchasers responsible for securing...
Sickle Cell Disease: How to Support 14 Million Lives Affected by 2050
Sickle Cell Disease (SCD) is a genetic blood disorder that affects millions of people worldwide. Between 2010 and 2050, an estimated 14 million babies will be affected globally, with the vast majority born in low- and middle-income countries (LMICs). This staggering...